Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Understanding Public Exposure to Patients Treated with Radioactive Iodine

by Global Biodefense Staff
April 2, 2013

Thyroid Cancer Treatment - Radioactive IodineThe U.S. Nuclear Regulatory Commission (NRC) is conducting market research to determine the availability and potential technical capability of the business community to manage the collection of data on doses to members of the public exposed to patients treated with Iodine-131. 

Radioactive iodine, mainly the isotope Iodine-131, is used in the diagnosis and treatment of several medical conditions, the primary ones in the present context being treatment of hyperthyroidism and thyroid cancer following thyroidectomy. 

Treatment protocols for these conditions generally call for administration of relatively large doses of Iodine-131, and such patients therefore pose the greatest potential for exposure of others. 

Patients are often released from the hospital following treatment if they meet NRC regulations, with the basic criterion for release being that “the total effective dose equivalent to any other individual from exposure to the released individual is not likely to exceed 5 mSv (0.5 rem).”

Potential sources would be required to execute the following activities: Measure External Doses to Selected Members of the Public; Measure Internal Doses to Selected Members of the Public; Time and Motion Study; Analysis of Data and Final Report; and Technical Support. 

The government is only seeking information on source capabilities at this time and has not issued a formal request for proposals. Further details are available under Solicitation Number: RES-13-092. The response deadline is April 16, 2013.

Tags: RadiationRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC